On December 21, 2021 XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, reported its Chief Executive Officer, Jim Neal, will present at the following upcoming investor conferences (Press release, Xoma, DEC 21, 2021, View Source [SID1234597543]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Biotech Showcase 2022 held virtually January 10-12 and January 17-19, 2022. Mr. Neal will hold a fireside chat titled, "Royalty Licenses: An Economic Asset Often Ignored." on Monday, January 10, 2022 at 10:30 AM PT.
H.C. Wainwright BioConnect Virtual Conference held January 10-13, 2022. The presentation will be available on demand beginning January 10, 2022 at 4:00 AM PT and can be accessed at https://bit.ly/3DWWNs8. The presentation can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com. A replay of the presentation will be available and archived on the site for 90 days after the event.